Terms: = Breast cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Treatment
13 results:
1. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
2. Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.
Eggemann H; Altmann U; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2018 Feb; 144(2):337-341. PubMed ID: 29098396
[TBL] [Abstract] [Full Text] [Related]
3. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Cameron D; Morden JP; Canney P; Velikova G; Coleman R; Bartlett J; Agrawal R; Banerji J; Bertelli G; Bloomfield D; Brunt AM; Earl H; Ellis P; Gaunt C; Gillman A; Hearfield N; Laing R; Murray N; Couper N; Stein RC; Verrill M; Wardley A; Barrett-Lee P; Bliss JM;
Lancet Oncol; 2017 Jul; 18(7):929-945. PubMed ID: 28600210
[TBL] [Abstract] [Full Text] [Related]
4. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract] [Full Text] [Related]
5. COP1, the negative regulator of etv1, influences prognosis in triple-negative breast cancer.
Ouyang M; Wang H; Ma J; Lü W; Li J; Yao C; Chang G; Bi J; Wang S; Wang W
BMC Cancer; 2015 Mar; 15():132. PubMed ID: 25884720
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.
Eggemann H; Ignatov A; Smith BJ; Altmann U; von Minckwitz G; Röhl FW; Jahn M; Costa SD
Breast Cancer Res Treat; 2013 Jan; 137(2):465-70. PubMed ID: 23224235
[TBL] [Abstract] [Full Text] [Related]
7. er81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
[TBL] [Abstract] [Full Text] [Related]
8. Gamma Knife radiosurgery to the surgical cavity following resection of brain metastases.
Jagannathan J; Yen CP; Ray DK; Schlesinger D; Oskouian RJ; Pouratian N; Shaffrey ME; Larner J; Sheehan JP
J Neurosurg; 2009 Sep; 111(3):431-8. PubMed ID: 19361267
[TBL] [Abstract] [Full Text] [Related]
9. Role of Sox-9, er81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells.
Endo Y; Deonauth K; Prahalad P; Hoxter B; Zhu Y; Byers SW
PLoS One; 2008 Jul; 3(7):e2714. PubMed ID: 18628953
[TBL] [Abstract] [Full Text] [Related]
10. The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays.
Smith L; Watson MB; O'Kane SL; Drew PJ; Lind MJ; Cawkwell L
Mol Cancer Ther; 2006 Aug; 5(8):2115-20. PubMed ID: 16928833
[TBL] [Abstract] [Full Text] [Related]
11. [Validity of the study of sentinel lymph nodes in the treatment of breast carcinoma].
Vieni S; Cipolla C; Fricano S; Amato C; Graceffa G; Sandonato L; Prinzi G; Latteri S; Latteri MA
Chir Ital; 2004; 56(2):215-22. PubMed ID: 15152513
[TBL] [Abstract] [Full Text] [Related]
12. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
[TBL] [Abstract] [Full Text] [Related]
13. [Transcription factors of the PEA3 group in mammary cancer].
Monté D; Baert JL; Laget MP; Defossez PA; Coutte L; Pelczar H; Angeli I; Dewitte F; Stéhelin D; De Launoit Y
Ann Endocrinol (Paris); 1995; 56(5):547-51. PubMed ID: 8597501
[TBL] [Abstract] [Full Text] [Related]
